High expression of interleukin-enhancer binding factor 3 predicts poor prognosis in patients with lung adenocarcinoma

Interleukin-enhancer binding factor 3 (ILF3) is a double-stranded RNA-binding protein that has been reported to contribute to the occurrence and progression of various malignant tumors. The aim of the present study was to evaluate the prognostic value of ILF3 and to apply this knowledge to avoid exc...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncol Lett
Autors principals: Xu, Zhangyan, Huang, Hua, Li, Xing, Ji, Cheng, Liu, Yifei, Liu, Xiaojuan, Zhu, Jun, Wang, Zhendong, Zhang, Haijian, Shi, Jiahai
Format: Artigo
Idioma:Inglês
Publicat: D.A. Spandidos 2020
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7039148/
https://ncbi.nlm.nih.gov/pubmed/32194712
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2020.11330
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars